Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 4 Propyl 4,5 Dihydrofuran 2(3H) One. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109553595A reveals mild chiral gamma-butyrolactone synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN109553595B reveals a cost-effective route to (R)-4-propyl-4,5-dihydrofuran-2(3H)-one using mild weak-base conditions and cheap diol starting materials.